FY2026 EPS Estimate for Astera Labs Raised by Analyst

Astera Labs, Inc. (NASDAQ:ALAB) – Equities researchers at Northland Securities lifted their FY2026 earnings per share estimates for shares of Astera Labs in a note issued to investors on Wednesday, November 4th. Northland Securities analyst G. Richard now expects that the company will post earnings per share of $2.99 for the year, up from their previous forecast of $2.75. Northland Securities has an “Outperform” rating and a $315.00 price target on the stock. The consensus estimate for Astera Labs’ current full-year earnings is $2.71 per share. Northland Securities also issued estimates for Astera Labs’ Q4 2026 earnings at $1.25 EPS, Q1 2027 earnings at $1.15 EPS, Q2 2027 earnings at $1.19 EPS, Q3 2027 earnings at $1.22 EPS, Q4 2027 earnings at $1.24 EPS and FY2027 earnings at $4.79 EPS.

ALAB has been the subject of several other reports. Needham & Company LLC lowered their price objective on shares of Astera Labs from $425.00 to $300.00 and set a “buy” rating for the company in a report on Wednesday, November 4th. Morgan Stanley upped their target price on Astera Labs from $382.00 to $389.00 and gave the stock an “overweight” rating in a report on Wednesday, November 4th. Susquehanna decreased their target price on Astera Labs from $310.00 to $258.00 and set a “neutral” rating for the company in a research report on Wednesday, November 4th. Jefferies Financial Group raised their target price on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Finally, BMO Capital Markets initiated coverage on Astera Labs in a research note on Thursday, November 5th. They issued an “outperform” rating and a $375.00 target price for the company. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $320.85.

Astera Labs Trading Up 13.7%

Shares of ALAB opened at $216.87 on Tuesday. Astera Labs has a 1-year low of $97.89 and a 1-year high of $499.48. The firm’s 50-day moving average price is $299.01 and its 200-day moving average price is $256.00. The firm has a market capitalization of $37.62 billion, a price-to-earnings ratio of 97.93 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.13. Astera Labs had a return on equity of 27.30% and a net margin of 29.64%. The firm had revenue of $584.90 million for the quarter, compared to analyst estimates of $550.78 million. During the same period last year, the company earned $0.49 EPS. The business’s quarterly revenue was up 153.6% compared to the same quarter last year.

Insider Activity

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the sale, the director directly owned 253,863 shares in the company, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel directly owned 96,542 shares of the company’s stock, valued at $32,872,551. This trade represents a 6.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 408,558 shares of company stock valued at $126,050,884. 10.40% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Astera Labs

Hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in Astera Labs during the 2nd quarter valued at $6,609,581,000. Atreides Management LP boosted its stake in shares of Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after acquiring an additional 1,754,593 shares during the last quarter. Van ECK Associates Corp boosted its stake in shares of Astera Labs by 20.0% during the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock worth $1,080,980,000 after acquiring an additional 373,545 shares during the last quarter. Bank of America Corp DE bought a new stake in shares of Astera Labs during the 2nd quarter valued at $1,061,791,000. Finally, Amundi grew its position in shares of Astera Labs by 77.9% during the 1st quarter. Amundi now owns 1,880,830 shares of the company’s stock valued at $206,139,000 after acquiring an additional 823,477 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Shares rallied alongside a broader tech-stock surge, providing a near-term market tailwind after a sharp recent pullback. Astera Labs rallies 14% on tech stock surge
• Positive Sentiment: Strong business momentum may support investor confidence: third-quarter revenue was about $585 million, and fourth-quarter revenue guidance had a midpoint of $740 million. An analyst upgrade highlighted rising revenue per accelerator as customers adopt higher-value Scorpio switches, alongside opportunities in optical and rack-level solutions. Astera Labs Is Increasing Their Revenue Per Accelerator
• Neutral Sentiment: The rebound follows a reported 26% five-session decline despite strong earnings and guidance. Competing semiconductor companies also reported robust data-center growth, underscoring strong sector demand but keeping the competitive backdrop in focus. Astera Labs Stock Drops 26% in a Week Despite Strong Earnings
• Negative Sentiment: Director Stefan Dyckerhoff reported selling shares in two transactions at an average price of $211.41. The sales were made under a pre-arranged Rule 10b5-1 plan, which may temper their significance as a signal of his outlook. SEC Form 4 filing

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems.

The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Founded in 2017 and headquartered in Santa Clara, California, Astera Labs serves the global cloud and computing markets.